The project aims to evaluate the cost-effectiveness, economic impact, and feasibility of integrating this herbal innovation into Thailand’s healthcare system. By applying Early HTA techniques, this study will provide insights for decision-makers, improve resource allocation, and support future investments in innovative medical solutions.67301075M

The development of medical innovation is one of Thailand’s key strategic priorities as outlined in the 13th National Economic and Social Development Plan (2023–2027). Milestone 4 identifies Thailand’s ambition to become a high-value medical and wellness hub, with the goal of strengthening the country’s capacity to generate economic value fr

The Thai Innovation List was established in 2015 to compile products and services developed through Thailand’s scientific and technological knowledge and research capacity. The initiative was designed to support and promote the utilization of Thai innovations for economic development and commercialization. Medical innovations account for approxim

The development of medical innovation is one of Thailand’s key strategic priorities as outlined in the 13th National Economic and Social Development Plan (2023–2027). Milestone 4 identifies Thailand’s ambition to become a high-value medical and wellness hub, with the goal of strengthening the country’s capacity to generate economic value fr

66183067HM017L0medical innovation,Early HTA,Health Technology

This study marks Thailand’s first application of Distributional Cost-Effectiveness Analysis (DCEA), demonstrating that the concept of “equity” can be incorporated into economic evaluation. The analysis examines dialysis options, namely peritoneal dialysis (PD) and hemodialysis (HD), for patients

Abstract The role of Health Technology Assessment (HTA) is evolving. Once seen primarily as a gatekeeper, HTA is increasingly viewed as a potential shaper of health system transformation. The first plenary session of the HTA International 2025 Annual Meeting, explored the potential for HTA to ado

Abstract Managing volatile organic compound (VOC) emissions in industrial complexes requires clear links between emission sources, atmospheric dispersion, and their contributions to ambient exposure. This study links VOC assessment and cost-effectiveness analysis to support emission management in

Highlights • Storage tanks and wastewater treatment systems were identified as the primary sources of benzene and 1,3-butadiene emissions. • AERMOD modeling showed VOC hotspots near industries, exposing nearby communities despite overall regulatory compliance. • Traffic emissions alone exceeded

This project aims to develop a practical guidebook on medical technology development. It is funded by the Department of Medical Sciences, Ministry of Public Health, and aims to explain the concepts, processes, and outcomes of medical technology development in the Thai context. This guidebook is intended to serve as a reliable internal reference doc